Recent PALI News
- Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC) • GlobeNewswire Inc. • 10/10/2024 12:30:00 PM
- Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC • GlobeNewswire Inc. • 10/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:31:12 PM
- Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis • GlobeNewswire Inc. • 09/25/2024 12:00:00 PM
- Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
- Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/19/2024 12:00:00 PM
- Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:11:13 PM
- Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Palisade Bio Participates in Virtual Investor “What this Means” Segment • GlobeNewswire Inc. • 07/31/2024 01:15:00 PM
- Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 07/29/2024 12:30:00 PM
- Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 07/19/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:19:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:13:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 12:10:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 09:15:31 PM
- Palisade Bio to Participate in the Virtual Investor Closing Bell Series • GlobeNewswire Inc. • 06/24/2024 01:00:00 PM
- Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences • GlobeNewswire Inc. • 06/21/2024 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 01:41:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 01:40:23 AM
- Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108 • GlobeNewswire Inc. • 06/11/2024 12:30:00 PM
- Palisade Bio to Present at the Virtual Investor Pitch Conference • GlobeNewswire Inc. • 06/10/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 11:44:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 11:44:32 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM